Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Integr Cancer Ther ; 20: 1534735421996824, 2021.
Article in English | MEDLINE | ID: mdl-33615860

ABSTRACT

Co-therapy with herbal extracts along with current clinical drugs is being increasingly recognized as a useful complementary treatment for cancer. The anti-cancer property of the phyto-derivative acetyl-11 keto ß boswellic acid (AKBA) has been studied in many cancers, including prostate cancer. However, the whole extract of the gum resin Boswellia serrata (BS) and anti-androgen enzalutamide has not been explored in prostate cancer to date. We hypothesized that the BS extract containing 30% (AKBA) with enzalutamide acted synergistically in the early phase of cancer, especially in LNCaP cells, by inhibiting androgen receptor (AR) and by reducing cell proliferation, and further, that the extract would be superior to the action of the active ingredient AKBA when used alone or in combination with enzalutamide. To test our hypothesis, we treated LNCaP cells with BS extract or AKBA and enzalutamide both individually and in combination to analyze cell viability under different levels of dihydrotestosterone (DHT). The inhibition of androgen receptor (AR) followed by the expression of prostate-specific antigen (PSA) and the efflux mechanism of the cells were analyzed to determine the effect of the combination on the cellular mechanism. Cells derived from prostate cancer patients were also tested with the combination. Only 6 µM enzalutamide along with BS in the range of 4.1 µg/ml to 16.4 µg/ml gave the best synergistic results with nearly 50% cell killing even though standard enzalutamide doses were as high as 48 µM. Cell killing was most effective at intermediate DHT concentrations of approximately 1 nM, which corresponds to normal physiological serum levels of DHT. The Pgp expression level and the androgen receptor expression levels were reduced under the combination treatment; the former helping to minimize drug efflux and the latter by reducing the sensitivity to hormonal changes. Furthermore, the combination reduced the PSA level secreted by the cells. In contrast, AKBA could not achieve the needed synergism for adequate cell killing at equivalent concentrations. The combination of enzalutamide and BS extract containing 30% AKBA because of their synergistic interaction is an attractive therapeutic option for treating early stage (hormone-dependent) prostate cancer and is superior to the use of AKBA alone.


Subject(s)
Benzamides/pharmacology , Boswellia , Nitriles/pharmacology , Phenylthiohydantoin/pharmacology , Plant Extracts , Prostatic Neoplasms/drug therapy , Testosterone , Triterpenes , Androgens , Boswellia/chemistry , Cell Line, Tumor , Humans , Male , Plant Extracts/pharmacology , Triterpenes/pharmacology
2.
ACS Appl Mater Interfaces ; 9(34): 28260-28272, 2017 Aug 30.
Article in English | MEDLINE | ID: mdl-28789518

ABSTRACT

This work focuses on the development of a nanoparticulate system that can be used for magnetic resonance (MR) imaging and E-field noninvasive radiofrequency (RF) hyperthermia. For this purpose, an amine-functional gold ion complex (GIC), [Au(III)(diethylenetriamine)Cl]Cl2, which generates heat upon RF exposure, was conjugated to carboxyl-functional poly(acrylic acid)-capped iron-oxide nanoparticles (IO-PAA NPs) to form IO-GIC NPs of size ∼100 nm. The multimodal superparamagnetic IO-GIC NPs produced T2-contrast on MR imaging and unlike IO-PAA NPs generated heat on RF exposure. The RF heating response of IO-GIC NPs was found to be dependent on the RF power, exposure period, and particle concentration. IO-GIC NPs at a concentration of 2.5 mg/mL showed a high heating response (δT) of ∼40 °C when exposed to 100 W RF power for 1 min. In vitro cytotoxicity measurements on NIH-3T3 fibroblast cells and 4T1 cancer cells showed that IO-GIC NPs are cytocompatible at high NP concentrations for up to 72 h. Upon in vitro RF exposure (100 W, 1 min), a high thermal response leads to cell death of 4T1 cancer cells incubated with IO-GIC NPs (1 mg/mL). Hematoxylin and eosin imaging of rat liver tissues injected with 100 µL of 2.5 mg/mL IO-GIC NPs and exposed to low RF power of 20 W for 10 min showed significant loss of tissue morphology at the site of injection, as against RF-exposed or nanoparticle-injected controls. In vivo MR imaging and noninvasive RF exposure of 4T1-tumor-bearing mice after IO-GIC NP administration showed T2 contrast enhancement and a localized generation of high temperatures in tumors, leading to tumor tissue damage. Furthermore, the administration of IO-GIC NPs followed by RF exposure showed no adverse acute toxicity effects in vivo. Thus, IO-GIC NPs show good promise as a theranostic agent for magnetic resonance imaging and noninvasive RF hyperthermia for cancer.


Subject(s)
Ferric Compounds/chemistry , Animals , Cell Line, Tumor , Gold , Hyperthermia, Induced , Magnetic Resonance Imaging , Mice , Rats , Theranostic Nanomedicine
3.
Appl Biochem Biotechnol ; 181(4): 1388-1400, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27812900

ABSTRACT

Prostate cancer is one of the most common malignancies among men worldwide. The main aim of the present work was to clarify the advantages of a nanoformulation of ayurvedic herbal plants. Specifically, we assessed the improved anticancer activity of Leucas aspera nanoparticles compared with methanolic crude extract in PC3 prostate cancer cells and normal cells. L. aspera is a plant that is used in ayurveda due to the antirheumatic, antipyretic, anti-inflammatory, antibacterial, anticancer, and cytotoxic activities. Nanoparticles of L. aspera were prepared from plant methanolic extracts. Cytotoxic effect was studied in the normal and prostate cancer cells. Size and morphology of the formulated nanoparticles was assessed using dynamic light scattering and scanning electron microscopy. In vitro cytotoxicity of L. aspera nanoparticles for PC3 cells was concentration- and time-dependent. In vitro hemolysis assay, cellular uptake studies, cell aggregation studies, and cell migration assay established the anticancerous activity of L. aspera in prostate cancer.


Subject(s)
Cell Movement/drug effects , Lamiaceae/chemistry , Nanomedicine , Plant Extracts/chemistry , Plant Extracts/pharmacology , Prostatic Neoplasms/pathology , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Biological Transport , Cell Aggregation/drug effects , Cell Line, Tumor , Drug Compounding , Humans , Male , Materials Testing , Nanoparticles/chemistry , Plant Extracts/metabolism
4.
Biomed Pharmacother ; 71: 201-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25960237

ABSTRACT

Prostate cancer has been diagnosed as the second most frequent and the sixth among the cancer causing deaths among men worldwide. There is a limited scope for the prevalent therapies as prostate cancer advances and they present adverse aftermaths that have put way for us to delve into naturally available anticancer agents. The main objective of the present work is to compile the advantages of ayurvedic herbal formulations with modern technology. Baliospermum montanum is a plant that is used in ayurveda for the treatment of cancer and the plant is studied to possess various constituents in it that are responsible for its anticancer activity. Stable nanoparticles of B. montanum were prepared from both the aqueous and ethanolic extracts of the plant and its cytotoxic effects were studied on prostate cancer and normal cell lines. Size analysis by DLS and SEM revealed the average size of nanoparticles prepared was 100±50 nm and 150±50 nm for the nanoparticles prepared from aqueous and ethanolic extract respectively. In vitro cytotoxicity showed a concentration and time dependent toxicity on prostate cancer cells with cell viability of 22% and 6% with maximum concentration of aqueous and ethanolic nanoparticles respectively, in 48 h. In vitro hemolysis assay confirmed that the prepared nanoparticles were compatible with blood with no occurrence of hemolysis. The nanoparticles showed a significant reduction in the colony forming ability and wound healing capacity of the prostate cancer cells. These studies hold the anti cancer potential of the B. montanum nanoparticles making it an important candidate for prostate cancer therapy.


Subject(s)
Apoptosis/drug effects , Cell Movement/drug effects , Euphorbiaceae/chemistry , Nanomedicine , Plant Extracts/pharmacology , Prostatic Neoplasms/pathology , Animals , Cell Line, Tumor , Cell Survival/drug effects , Clone Cells , Hemolysis/drug effects , Humans , Male , Mice , NIH 3T3 Cells , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Particle Size , Phytotherapy , Spectroscopy, Fourier Transform Infrared , Tumor Stem Cell Assay
5.
Nanotechnology ; 26(16): 161001, 2015 Apr 24.
Article in English | MEDLINE | ID: mdl-25824014

ABSTRACT

In this study, graphene oxide (GO) nanoflakes (0.5 and 1 wt%) were incorporated into a gelatin-hydroxyapatite (GHA) matrix through a freeze drying technique and its effect to enhance mechanical strength and osteogenic differentiation was studied. The GHA matrix with GO demonstrated less brittleness in comparison to GHA scaffolds. There was no significant difference in mechanical strength between GOGHA0.5 and GOGHA1.0 scaffolds. When the scaffolds were immersed in phosphate buffered saline (to mimic physiologic condition) for 60 days, around 50-60% of GO was released in sustained and linear manner and the concentration was within the toxicity limit as reported earlier. Further, GOGHA0.5 scaffolds were continued for cell culture experiments, wherein the scaffold induced osteogenic differentiation of human adipose derived mesenchymal stem cells without providing supplements like dexamethasone, L-ascorbic acid and ß glycerophosphate in the medium. The level of osteogenic differentiation of stem cells was comparable to those cultured on GHA scaffolds with osteogenic supplements. Thus biocompatible, biodegradable and porous GO reinforced gelatin-HA 3D scaffolds may serve as a suitable candidate in promoting bone regeneration in orthopaedics.


Subject(s)
Cell Differentiation/drug effects , Durapatite/chemistry , Graphite/chemistry , Mesenchymal Stem Cells/drug effects , Nanostructures/chemistry , Osteogenesis/drug effects , Tissue Scaffolds/chemistry , Cell Line , Cell Survival/drug effects , Gelatin/chemistry , Graphite/pharmacology , Graphite/toxicity , Humans , Nanostructures/toxicity
6.
Curr Drug Deliv ; 12(6): 709-16, 2015.
Article in English | MEDLINE | ID: mdl-25772029

ABSTRACT

Stable nano-formulation of Plumbagin nanoparticles from Plumbago zeylanica root extract was explored as a potential natural drug against prostate cancer. Size and morphology analysis by DLS, SEM and AFM revealed the average size of nanoparticles prepared was 100±50nm. In vitro cytotoxicity showed concentration and time dependent toxicity on prostate cancer cells. However, plumbagin crude extract found to be highly toxic to normal cells when compared to plumbagin nanoformulation, thus confirming nano plumbagin cytocompatibility with normal cells and dose dependent toxicity to prostate cells. In vitro hemolysis assay confirmed the blood biocompatibility of the plumbagin nanoparticles. In wound healing assay, plumbagin nanoparticles provided clues that it might play an important role in the anti-migration of prostate cancer cells. DNA fragmentation revealed that partial apoptosis induction by plumbagin nanoparticles could be expected as a potent anti-cancer effect towards prostate cancer.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Nanoparticles , Naphthoquinones/administration & dosage , Prostatic Neoplasms/drug therapy , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/toxicity , Apoptosis/drug effects , Cell Line, Tumor , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Humans , Hydrogen-Ion Concentration , Male , Mice , NIH 3T3 Cells , Naphthoquinones/pharmacology , Naphthoquinones/toxicity , Particle Size , Plant Extracts/administration & dosage , Plant Extracts/toxicity , Plumbaginaceae/chemistry , Prostatic Neoplasms/pathology , Time Factors
7.
ACS Appl Mater Interfaces ; 6(11): 8080-9, 2014 Jun 11.
Article in English | MEDLINE | ID: mdl-24842534

ABSTRACT

Nanoparticles of varying composition, size, shape, and architecture have been explored for use as photothermal agents in the field of cancer nanomedicine. Among them, gold nanoparticles provide a simple platform for thermal ablation owing to its biocompatibility in vivo. However, the synthesis of such gold nanoparticles exhibiting suitable properties for photothermal activity involves cumbersome routes using toxic chemicals as capping agents, which can cause concerns in vivo. Herein, gold nanoparticles, synthesized using green chemistry routes possessing near-infrared (NIR) absorbance facilitating photothermal therapy, would be a viable alternative. In this study, anisotropic gold nanoparticles were synthesized using an aqueous route with cocoa extract which served both as a reducing and stabilizing agent. The as-prepared gold nanoparticles were subjected to density gradient centrifugation to maximize its NIR absorption in the wavelength range of 800-1000 nm. The particles also showed good biocompatibility when tested in vitro using A431, MDA-MB231, L929, and NIH-3T3 cell lines up to concentrations of 200 µg/mL. Cell death induced in epidermoid carcinoma A431 cells upon irradiation with a femtosecond laser at 800 nm at a low power density of 6 W/cm(2) proved the suitability of green synthesized NIR absorbing anisotropic gold nanoparticles for photothermal ablation of cancer cells. These gold nanoparticles also showed good X-ray contrast when tested using computed tomography (CT), proving their feasibility for use as a contrast agent as well. This is the first report on green synthesized anisotropic and cytocompatible gold nanoparticles without any capping agents and their suitability for photothermal therapy.


Subject(s)
Gold/chemistry , Metal Nanoparticles/chemistry , Neoplasms/therapy , Phototherapy , Animals , Biocompatible Materials , Cell Line, Tumor , Humans , Microscopy, Electron, Transmission , Spectroscopy, Near-Infrared
8.
J Nanosci Nanotechnol ; 14(1): 841-52, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24730302

ABSTRACT

Recent advancements in cancer nanotechnology have facilitated a better way to diagnosis and provide therapy for prostate cancer. Nanotechnology has the potential to battle tumors at the site, where the cancer begins. There is a need to improve the therapeutic availabilities and the effectiveness of conventional chemotherapeutic agents for prostate cancer. Many therapeutic NPs have been developed with nanotechnology that can specifically target and deliver variety of agents including chemo drugs to destruct the prostate cancer cells without causing any damage to the healthy cells. Theranostic NPs have been developed to specifically target the prostate cancer cells using targeting ligands and to release the anticancer agents in a controlled and time-dependent manner for cancer therapy in combination with assisted imaging to monitor the effectiveness of the therapy in real time. The natural products and surface-modified polymers and metallic NPs have evolved as promising nanomaterials for targeted prostate cancer treatment. This review focuses on the role of alternative medicine, polymeric and metallic and metal oxide NPs in prostate cancer theranostics.


Subject(s)
Antineoplastic Agents/administration & dosage , Image Enhancement/methods , Molecular Imaging/methods , Nanocapsules/administration & dosage , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/therapy , Contrast Media/chemical synthesis , Drug Compounding/methods , Humans , Male , Nanocapsules/chemistry
9.
Carbohydr Polym ; 92(2): 1561-5, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23399189

ABSTRACT

In this work, Hemigraphis alternata extract incorporated chitosan scaffold was synthesized and characterized for wound healing. The antibacterial activity of Hemigraphis incorporated chitosan scaffold (HIC) against Escherichia coli and Staphylococcus aureus was evaluated which showed a reduction in total colony forming units by 45-folds toward E. coli and 25-fold against S. aureus respectively. Cell viability studies using Human Dermal Fibroblast cells (HDF) showed 90% viability even at 48 h when compared to the chitosan control. The herbal scaffold made from chitosan was highly haemostatic and antibacterial. The obtained results were in support that the herbal scaffold can be effectively applied for infectious wounds.


Subject(s)
Acanthaceae/chemistry , Chitosan/chemistry , Chitosan/pharmacology , Hydrogels/chemistry , Plant Extracts/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacology , Biocompatible Materials/chemistry , Biocompatible Materials/metabolism , Biocompatible Materials/pharmacology , Blood Coagulation/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Chitosan/metabolism , Escherichia coli/drug effects , Fibroblasts/cytology , Fibroblasts/drug effects , Humans , Platelet Activation/drug effects , Porosity , Staphylococcus aureus/drug effects , Water/chemistry
10.
Curr Drug Deliv ; 10(3): 326-35, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23294467

ABSTRACT

Ovarian cancer is the ninth most common cancer amongst women and ranked as fifth in terms of the cause of cancer related mortality accounting for more deaths than any other cancer of the female reproductive system. Gemcitabine is the most common chemotherapeutic agent used in the treatment of ovarian cancer despite of its disadvantage of having a very lesser half life. In this study, we have envisaged the use of a highly porous, biomimetic and implantable pectin scaffold embedded with gemcitabine loaded fibrin nanoconstructs to improve the half life of the drug, thereby providing localized therapy for ovarian cancer. The controlled and sustained release of the chemokine from the scaffold system was extensively analyzed in vitro different pH environments. The composite scaffolds were found to be highly biocompatible when tested with mammalian cell lines. The excellent cytotoxicity and apoptosis responses induced in ovarian cancer, PA- 1 cell lines proved that the nanocomposite Pectin scaffolds loaded with specific chemokine can be used as implantable "therapeutic wafers" for distracting metastatic cancer cells and thus improve the survival rate of ovarian cancer afflicted individuals.


Subject(s)
Antimetabolites, Antineoplastic/chemistry , Deoxycytidine/analogs & derivatives , Drug Delivery Systems , Nanocomposites/chemistry , Tissue Scaffolds , Antimetabolites, Antineoplastic/administration & dosage , Cell Adhesion , Cell Line, Tumor , Cell Survival/drug effects , Chitosan/chemistry , Deoxycytidine/administration & dosage , Deoxycytidine/chemistry , Female , Fibrin/chemistry , Humans , Nanocomposites/administration & dosage , Ovarian Neoplasms/drug therapy , Pectins/chemistry , Porosity , Gemcitabine
11.
J Biomed Nanotechnol ; 8(6): 901-11, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23029998

ABSTRACT

Synthesis of biocompatible gold nanoparticles having tunable optical absorbance finds immense use in biomedical applications such as cancer diagnosis and photothermal therapy. Hence, it is imperative to develop environment and bio-friendly green chemical processes that aid in preparing gold nanoparticles with tunable optical properties. In the present work, phytochemicals present in the medicinal herb, viz., garlic, were used to provide the dual effects of reduction of gold salts to gold nanoparticles as well as stabilization, in a single step process. The optical tunability of nanogold with respect to concentration of precursor and volume of garlic extract, processing conditions of garlic, its differing molecular weight fractions, reaction time and temperature has been demonstrated. The presence of a range of anisotropic nanogold including nanotriangles, nanorods and nanospheres as evident from TEM endows the colloid with a tunable optical absorption, specifically into the near infrared region. In vitro stability studies of the colloidal suspension in various media including saline, BSA, histidine and PBS showed that gold nanoparticles did not aggregate with time or differing pH conditions. The role of the garlic phytochemicals in providing stability against agglomeration was also substantiated by FTIR studies. Cytotoxicity studies performed using spherical and anisotropic gold nanoparticles on MCF-7 and L929 cell lines proved the biocompatibility of the material up to high doses of 500 microg/ml. The present work highlights the role of garlic phytochemicals in preparing biocompatible metallic gold nanoparticles with tunable optical properties and good in vitro stability, suggesting its potential use for molecular imaging or therapeutic nanomedicines.


Subject(s)
Biocompatible Materials/chemistry , Garlic/metabolism , Gold/chemistry , Green Chemistry Technology , Metal Nanoparticles/chemistry , Nanomedicine/methods , Nanoparticles/chemistry , Phytotherapy/methods , Surface Plasmon Resonance/methods , Animals , Anisotropy , Cell Line, Tumor , Humans , Hydrogen-Ion Concentration , Mice , Microscopy, Electron, Transmission/methods , Spectroscopy, Fourier Transform Infrared/methods , Spectroscopy, Near-Infrared/methods , Temperature , X-Ray Diffraction
12.
Nanoscale ; 4(1): 239-50, 2012 Jan 07.
Article in English | MEDLINE | ID: mdl-22080352

ABSTRACT

In this study, curcumin loaded chitin nanogels (CCNGs) were developed using biocompatible and biodegradable chitin with an anticancer curcumin drug. Chitin, as well as curcumin, is insoluble in water. However, the developed CCNGs form a very good and stable dispersion in water. The CCNGs were analyzed by DLS, SEM and FTIR and showed spherical particles in a size range of 70-80 nm. The CCNGs showed higher release at acidic pH compared to neutral pH. The cytotoxicity of the nanogels were analyzed on human dermal fibroblast cells (HDF) and A375 (human melanoma) cell lines and the results show that CCNGs have specific toxicity on melanoma in a concentration range of 0.1-1.0 mg mL(-1), but less toxicity towards HDF cells. The confocal analysis confirmed the uptake of CCNGs by A375. The apoptotic effect of CCNGs was analyzed by a flow-cytometric assay and the results indicate that CCNGs at the higher concentration of the cytotoxic range showed comparable apoptosis as the control curcumin, in which there was negligible apoptosis induced by the control chitin nanogels. The CCNGs showed a 4-fold increase in steady state transdermal flux of curcumin as compared to that of control curcumin solution. The histopathology studies of the porcine skin samples treated with the prepared materials showed loosening of the horny layer of the epidermis, facilitating penetration with no observed signs of inflammation. These results suggest that the formulated CCNGs offer specific advantage for the treatment of melanoma, the most common and serious type of skin cancer, by effective transdermal penetration.


Subject(s)
Antineoplastic Agents/toxicity , Chitin/chemistry , Curcumin/toxicity , Melanoma/drug therapy , Polyethylene Glycols/chemistry , Polyethyleneimine/chemistry , Skin Neoplasms/drug therapy , Administration, Cutaneous , Animals , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Cell Line, Tumor , Curcumin/therapeutic use , Drug Carriers/chemistry , Humans , Melanoma/pathology , Nanogels , Skin Neoplasms/pathology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL